OX40 signaling favors the induction of TH9 cells and airway inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OX40 signaling favors the induction of TH9 cells and airway inflammation

Published:2012-07-29 Issue:10 Volume:13 Page:981-990
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Xiao Xiang,Balasubramanian Savithri,Liu Wentao,Chu Xiufeng,Wang Haibin,Taparowsky Elizabeth J,Fu Yang-Xin,Choi Yongwon,Walsh Matthew C,Li Xian Chang

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.2390.pdf

Reference49 articles.

1. Janeway, C.A. & Bottomly, K. Signals and signs for lymphocyte responses. Cell 76, 275–285 (1994).

2. Li, X.C., Rothstein, D.M. & Sayegh, M.H. Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229, 271–293 (2009).

3. Dong, C. Diversification of T helper cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329–333 (2006).

4. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory cells. Nature 441, 235–238 (2006).

5. Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192–202 (2010).

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma;Mucosal Immunology;2024-08

2. MicroRNA-19b exacerbates systemic sclerosis through promoting Th9 cells;Cell Reports;2024-08

3. Altered cancer metabolism and implications for next-generation CAR T-cell therapies;Pharmacology & Therapeutics;2024-07

4. Locus of (IL-9) control: IL9 epigenetic regulation in cellular function and human disease;Experimental & Molecular Medicine;2024-06-03

5. Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer;Experimental Hematology & Oncology;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3